D

Domain Therapeutics

104 employees

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

Investor insights

Sectors invested in

Health Care1
Pharmaceutical1
Biotechnology1

Funding rounds participated in

$8.4M sweet spot round size

Most of their 2 investments are in rounds between $6.9M and $9.9M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2008

Investments made

E

Ermium Therapeutics raised $6.9M on September 12, 2019

Investors: SATT idfinnov, Idinvest Partners and Domain Therapeutics

U

Undisclosed raised $9.9M on October 18, 2016

Investors: Medicxi and Domain Therapeutics

Funding rounds raised

Total raised

$41M

from 27 investors over 27 rounds

D

Domain Therapeutics raised $41M on May 10, 2022

Investors: Schroders Capital, 3B Future Health Fund, Theodorus Investment Funds, Omnes, adMare BioInnovations, Viva BioInnovator and Seventure Partners

D

Domain Therapeutics raised $6.7M on January 13, 2020

Investors: Crédit industriel et commercial (CIC), Caisse d’Epargne and Banque Populaire Alsace Lorraine Champagne (BPALC)

D

Domain Therapeutics raised $3.9M on May 28, 2019

Investors: Seventure Partners

D

Domain Therapeutics raised $2.5M on July 17, 2012

Investors: Sodiv, Auriga Partners and Seventure Partners

D

Domain Therapeutics raised $2.8M on December 12, 2008

Investors: ALSACREA

D

Domain Therapeutics raised $10M on October 1, 2006

Investors: Siparex, Andera Partners, Idinvest Partners, Auriga Partners and Sofinnova Partners

D

Domain Therapeutics raised $19M on May 1, 2004

Investors: Andera Partners, Auriga Partners, Idinvest Partners, Siparex and Sofinnova Partners

D

Domain Therapeutics raised $2.6M on February 1, 2002

Investors: Sofinnova Partners and Auriga Partners

FAQ